{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:13:18Z","timestamp":1785791598872,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.cld.2022.08.001","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T04:33:18Z","timestamp":1666067598000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Chronic Hepatitis B Virus and Hepatitis D Virus"],"prefix":"10.1016","volume":"27","author":[{"given":"Ann","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Gish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2022.08.001_bib1","series-title":"Hepatitis B","year":"2021"},{"issue":"3","key":"10.1016\/j.cld.2022.08.001_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cld.2019.04.001","article-title":"Global perspective on hepatitis B virus infections in the era of effective vaccines","volume":"23","author":"Gomes","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2022.08.001_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.cld.2022.08.001_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.28109","article-title":"Prevalence of chronic hepatitis B virus (HBV) infection in U.S. Households: National Health and Nutrition Examination survey (NHANES), 1988-2012","volume":"63","author":"Roberts","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2022.08.001_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/hep.31782","article-title":"An updated assessment of chronic hepatitis B prevalence among foreign-born persons living in the United States","volume":"74","author":"Wong","year":"2021","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"3","key":"10.1016\/j.cld.2022.08.001_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.15585\/mmwr.mm6503a2","article-title":"Increases in acute hepatitis B virus infections - Kentucky, Tennessee, and West Virginia, 2006-2013","volume":"65","author":"Harris","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cld.2022.08.001_bib8","author":"Weng"},{"issue":"15","key":"10.1016\/j.cld.2022.08.001_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.15585\/mmwr.mm6715a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cld.2022.08.001_bib10","author":"Weng"},{"key":"10.1016\/j.cld.2022.08.001_bib12","author":"Kroger"},{"issue":"1","key":"10.1016\/j.cld.2022.08.001_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2022.08.001_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2022.08.001_bib16","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 Hepatitis B Guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.cld.2022.08.001_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific Clinical Practice Guidelines on the Management of Hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"issue":"10","key":"10.1016\/j.cld.2022.08.001_bib18","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.cgh.2020.04.091","article-title":"Should treatment indications for chronic hepatitis B be expanded?","volume":"19","author":"Jeng","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"28","key":"10.1016\/j.cld.2022.08.001_bib19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.15585\/mmwr.mm6728a2","article-title":"Access to treatment for hepatitis B virus infection - worldwide, 2016","volume":"67","author":"Hutin","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.cld.2022.08.001_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hep.23348","article-title":"Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B","volume":"51","author":"Chen","year":"2010","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"10.1016\/j.cld.2022.08.001_bib21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1053\/j.gastro.2011.06.036","article-title":"Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma","volume":"141","author":"Chen","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2022.08.001_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41575-020-00398-x","article-title":"Extending treatment eligibility for chronic hepatitis B virus infection","volume":"18","author":"McNaughton","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2022.08.001_bib23","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/ajg.2009.248","article-title":"Histological disease in Asian-Americans with chronic hepatitis B, high hepatitis B virus DNA, and normal alanine aminotransferase levels","volume":"104","author":"Nguyen","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2022.08.001_bib24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/jcph.409","article-title":"A\u00a0meta-analysis comparing the efficacy of entecavir and tenofovir for the treatment of chronic hepatitis B infection","volume":"55","author":"Zuo","year":"2015","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.cld.2022.08.001_bib25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s12885-019-5735-9","article-title":"The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cld.2022.08.001_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev-med-080119-103356","article-title":"New therapeutics for hepatitis B: the road to cure","volume":"72","author":"Naggie","year":"2021","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.cld.2022.08.001_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010213","article-title":"Hepatitis B virus cure: targets and future therapies","volume":"22","author":"Lee","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.cld.2022.08.001_bib29","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2893.2010.01353.x","article-title":"Natural history and treatment of chronic delta hepatitis","volume":"17","author":"Yurdaydin","year":"2010","journal-title":"J\u00a0Viral Hepat"},{"issue":"4","key":"10.1016\/j.cld.2022.08.001_bib30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7326\/0003-4819-98-4-437","article-title":"Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. an active and progressive disease unresponsive to immunosuppressive treatment","volume":"98","author":"Rizzetto","year":"1983","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.cld.2022.08.001_bib31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gutjnl-2018-317403","article-title":"Devil hepatitis D: an orphan disease or largely underdiagnosed?","volume":"68","author":"Wedemeyer","year":"2019","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.cld.2022.08.001_bib32","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/infdis\/jiz633","article-title":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection","volume":"221","author":"Miao","year":"2020","journal-title":"J\u00a0Iinfect Dis"},{"issue":"3","key":"10.1016\/j.cld.2022.08.001_bib33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: systematic review and meta-analysis","volume":"73","author":"Stockdale","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2022.08.001_bib34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/gutjnl-2018-316601","article-title":"Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis","volume":"68","author":"Chen","year":"2019","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cld.2022.08.001_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/gastro\/goz023","article-title":"Hepatitis D infection: from initial discovery to current investigational therapies","volume":"7","author":"Da","year":"2019","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"3","key":"10.1016\/j.cld.2022.08.001_bib36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2015.04.025","article-title":"Delta hepatitis within the Veterans Affairs Medical System in the United States: prevalence, risk factors, and outcomes","volume":"63","author":"Kushner","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2022.08.001_bib37","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/jgh.12217","article-title":"Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California","volume":"28","author":"Gish","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.08.001_bib38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1086\/655808","article-title":"Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users","volume":"202","author":"Kucirka","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.cld.2022.08.001_bib39","first-page":"647","article-title":"Hepatitis D virus: a call to screening","volume":"10","author":"Ahn","year":"2014","journal-title":"Gastroenterol Hepatol (N\u00a0Y)"},{"issue":"4","key":"10.1016\/j.cld.2022.08.001_bib40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/cid\/ciz001","article-title":"Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011-2016","volume":"69","author":"Patel","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.cld.2022.08.001_bib41","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa0912696","article-title":"Peginterferon plus adefovir versus either drug alone for hepatitis delta","volume":"364","author":"Wedemeyer","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2022.08.001_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11908-012-0307-z","article-title":"Treatment options for hepatitis delta virus infection","volume":"15","author":"Heidrich","year":"2013","journal-title":"Curr Infect Dis Rep"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:58:52Z","timestamp":1761069532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326122000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1089326122000654"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2022.08.001","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Hepatitis B Virus and Hepatitis D Virus","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2022.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}